NIFTY 50▲24,834.85
428.75 (1.76%)
SENSEX▲81,332.72
1292.92 (1.62%)
NIFTY BANK▲51,295.95
407.20 (0.80%)
INDIAN RAILWAY FINANCE CORP▼183.44
-0.12 (-0.07%)
TATA MOTORS▲1,118.30
27.35 (2.51%)
TATA STEEL▲162.55
5.16 (3.28%)
TATA POWER▲444.70
21.35 (5.04%)
SUZLON ENERGY▲61.89
0.42 (0.68%)
RAIL VIKAS NIGAM▼552.35
-23.35 (-4.06%)
INDIAN RENEWABLE ENERGY▼258.03
-3.15 (-1.21%)
VODAFONE IDEA▲15.98
0.80 (5.27%)
RELIANCE INDUSTRIES▲3,018.05
33.25 (1.11%)
YES BANK▲24.97
0.35 (1.42%)
ADANI POWER▲712.65
17.45 (2.51%)
NHPC▲104.62
2.66 (2.61%)
STATE BANK OF INDIA▲862.45
13.95 (1.64%)
HDFC BANK▲1,618.15
1.55 (0.10%)
RELIANCE POWER▲29.77
0.08 (0.27%)
JIO FIN SERVICES LTD▲331.90
2.70 (0.82%)
ZOMATO▲224.62
5.31 (2.42%)
ADANI PORT & SEZ▲1,542.75
55.75 (3.75%)
BHARAT ELECTRONICS▲309.90
8.45 (2.80%)
INDIAN RAILWAY TOURISM CORP▲984.15
15.00 (1.55%)
INDIAN OIL CORP▼176.55
-0.30 (-0.17%)
RATTANINDIA POWER▲16.87
0.06 (0.36%)
MRF▲1,38,870.35
1280.25 (0.93%)
ADANI ENTERPRISES▲3,080.50
107.00 (3.60%)
JAIPRAKASH POWER VENTURES▲19.66
0.83 (4.41%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE646B01010.png)
Medicamen Biotech Share Price
MEDICAMEQ
₹449.75-₹2.90 (-0.64%) TodayLast updated on 26 Jul, 2024 | 15:52 IST
₹447.85₹459.55
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹454.80 | Close₹452.65 |
Circuit range₹539.70 - ₹359.80 | Day range₹447.85 - ₹459.55 | Year range₹355.45 - ₹845.00 |
Volume14,356 | Avg. traded₹452.74 | Revenue (12m)₹179 Crs |
Medicamen BiotechMedicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider company. The Company is engaged in manufacturing of diverse range of pharmaceutical products oral solids, oral liquids, ointment for non-oncology products range and also produces tablets, capsule/lyohilized/dry powder injections for oncology product range. It focuses on oncology therapeutics, and other generics. The Company manufactures a range of products, including tablets, capsules, liquid syrup, dry syrup, such as beta-lactum and non-beta lactum, and ointments. The Company primarily focuses on oncology therapeutics. It is also focused on other therapeutic areas, such as cardiology, central nervous system (CNS), diabetology and pain management. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, Bortezomib, Busulfan, Capecitabine, Cisplatin, Erlotinib HCL, Gefitinib, Imatinib mesylate, Lenalidomide, Letrozole, Melphalan, and Pazopanib.
Medicamen Biotech Key indicators
52 week high₹845.00 | 52 week low₹355.45 | P/E ratio56.23 |
P/B ratio2.97 | ROE9.17% | ROCE10.95% |
Dividend yield0.22% | Debt/Equity ratio0.14 | EPS11.86 |
Learn more
Featured in
Investment checklist: (1/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin19.64% | Net profit margin10.88% |
ROE9.17% | ROA6% |
ROCE10.95% |
Learn more
Medicamen Biotech Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Jul 26 2024 | ₹454.80 | ₹449.75 | -0.64% |
Thu, Jul 25 2024 | ₹453.20 | ₹452.65 | -0.13% |
Wed, Jul 24 2024 | ₹456.15 | ₹453.25 | -0.64% |
Tue, Jul 23 2024 | ₹450.40 | ₹456.15 | |
Mon, Jul 22 2024 | ₹453.50 | ₹454.50 | |
Fri, Jul 19 2024 | ₹470.50 | ₹453.10 | -3.19% |
Thu, Jul 18 2024 | ₹480.00 | ₹468.05 | -1.73% |
Tue, Jul 16 2024 | ₹472.00 | ₹476.30 | -0.05% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 20 Sep 2023
Dividend • ₹1/share
Ex date 19 Sep 2022
Dividend • ₹1/share
Ex date
Learn more